In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

From crippling fatigue to brain fog, CML treatment can affect your body in ways that go beyond the usual side effects.

Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...

Inc. (Market cap: $34.46M) has reported its financial performance for the fourth quarter of 2023, highlighting a steady cash flow and strategic advancements in its clinical pipeline. According to ...

Acquired miR-142 deficit in leukemic stem cells has been associated with chronic myeloid leukemia blast crisis. Here the authors show that acquired miR-142 deficit in T cells further enables ...

Saeed Sadeghi, MD, discusses treatment options in low-risk myelodysplastic syndrome at a Case-Based Roundtable event.

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) patients with a new all-tablet treatment showing impressive results.

and patients were counted a maximum of once per discontinuation reason and could have been counted under multiple discontinuation reasons. CLL denotes chronic lymphocytic leukemia.

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his life by 30 years.

The chimeric BCR–ABL oncoprotein is the molecular hallmark of chronic myelogenous leukemia (CML). BCR–ABL contains nuclear import and export signals but it is localized only in the cytoplasm ...

Weinstein, who suffers from chronic myeloid leukemia, diabetes and heart problems, objected, saying he doesn’t have much time left. “I won’t be there for April,” the 72-year-old said from ...